Search for non-lactam inhibitors of mtb β-lactamase led to its open shape in apo state: new concept for antibiotic design
Abstract Mtb β-lactamase (BlaC) is extremely efficient in hydrolyzing ß-lactam antibiotics which renders/leads to protection and/or resistance to this bug. There is a compelling need to develop new non-lactam inhibitors which can bind and inhibit BlaC, but cannot be hydrolyzed, thus neutralizing thi...
Guardado en:
Autores principales: | Amin Sagar, Nazia Haleem, Yaawar Mir Bashir, Ashish |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b4ce3fcb17334e4faf9e86a12a35893b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Quantitative Insights Into β-Lactamase Inhibitor’s Contribution in the Treatment of Carbapenemase-Producing Organisms With β-Lactams
por: Yanfang Feng, et al.
Publicado: (2021) -
Heteroresistance to beta-lactam antibiotics may often be a stage in the progression to antibiotic resistance.
por: Victor I Band, et al.
Publicado: (2021) -
In Vivo Secretion of β-Lactamase-Carrying Outer Membrane Vesicles as a Mechanism of β-Lactam Therapy Failure
por: Martina Bielaszewska, et al.
Publicado: (2021) -
Clinical on-site monitoring of ß-lactam antibiotics for a personalized antibiotherapy
por: R. Bruch, et al.
Publicado: (2017) -
Escape mutations circumvent a tradeoff between resistance to a beta-lactam and resistance to a beta-lactamase inhibitor
por: Dor Russ, et al.
Publicado: (2020)